[
    [
        {
            "time": "",
            "original_text": "医药行业一周观察：龙头延续回调趋势 关注二线投资机会",
            "features": {
                "keywords": [
                    "医药行业",
                    "龙头",
                    "回调趋势",
                    "二线投资机会"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业一周观察：龙头延续回调趋势 关注二线投资机会",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华西证券---CXO行业系列报告：CDMO行业，基于工程师红利和高固定资产产出比，中长期战略性看好国内CDMO行业【行业研究】",
            "features": {
                "keywords": [
                    "华西证券",
                    "CXO行业",
                    "CDMO行业",
                    "工程师红利",
                    "高固定资产产出比",
                    "中长期看好"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "CXO",
                    "CDMO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华西证券---CXO行业系列报告：CDMO行业，基于工程师红利和高固定资产产出比，中长期战略性看好国内CDMO行业【行业研究】",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业报告：医药板块大幅调整之后的布局思路",
            "features": {
                "keywords": [
                    "医药生物行业",
                    "医药板块",
                    "大幅调整",
                    "布局思路"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药生物行业报告：医药板块大幅调整之后的布局思路",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]